Background Remdesivir is considered to be a specific drug for treating coronavirus disease
2019. This systematic review aims to evaluate the clinical efficacy and risk of remdesivir …

The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in December 2019 in Wuhan challenges pediatric oncologists in an unexpected way. We …

Background Childhood cancer represents a leading cause of death and disease burden in
high income countries (HICs) and low-and-middle income countries (LMICs). It is postulated …

We aimed to study the outcomes of COVID‐19 in paediatric cancer patients. On 26 October
2021, we did a systematic search for relevant articles in seven electronic databases followed …

The World Health Organization (WHO) first declared the severe acute respiratory syndrome
coronavirus-2 (SAR-CoV-2) a pandemic on 11 March 2020 [1]. Although children with …

Background Risk stratification is a cornerstone of the Pediatric Infectious Diseases Society
COVID-19 treatment guidance. This systematic review and meta-analysis aimed to define …

Patients with COVID-19 are at risk of developing secondary complications such as invasive
pulmonary aspergillosis and mucormycosis. This is a retrospective study including all cancer …

Background: Considering the widespread COVID-19 pandemic and its impact, especially on
children, particularly those with cancer, in terms of transmission risk, mortality, and the …

Background Blood cancer is the most common type of cancer and the leading cause of
death by disease past infancy among children. Children with blood cancer are vulnerable …

The COVID-19 pandemic has resulted in millions of fatalities worldwide. The case of
pediatric cancer patients stands out since, despite being considered a population at risk, few …